Keep An Eye On Quit-Smoking Patients Using Varenicline (Champix), Says National Prescribing Service Ltd, Australia

National Prescribing Service Limited (NPS) wants health professionals to be aware that following the release of a study in the USA recently the spotlight is back on varenicline (Champix). Reports of serious accidents, heart and vision problems, are fueling debate around the safety of the medicine. NPS urges health professionals to monitor patients using varenicline for any behaviour and/or mood changes or any unusual symptoms or events that occur while taking the medicine.

More: continued here

Filed under: Smoking / Quit Smoking on June 1st, 2008